QART Medical

3D Imaging, Healthcare, InVitro Fertilization
Computer Vision Deep Learning

Business Overview

QART (Quantitative Assisted Reproductive Technologies) Medical, a clinical-stage MedTech company, addressing the global infertility epidemic. The Company develops a breakthrough solution for highly informative characterization and selection of sperm cells for in-vitro fertilization (IVF), aiming to create a new and better gold standard in the ART market. The QART system aims to improve current success rates of Intra-Cytoplasmic Sperm Injection (ICSI) by:
* Quantitatively characterizing the morphology and contents of individual sperm cells with 3D topographic imaging
* Providing quantitative DNA integrity information, on a cell-by-cell basis
* Automatically sorting a semen sample according to objective consensus criteria.

Operating Status
Active
Founded
April 2018
Employees
8
Business model
B2B
Offering type
Hardware, Software
Funding stage
Seed
Business stage
Product Development
Sectors
3D Imaging, Healthcare, InVitro Fertilization

Founders

QART Medical
Nathan Shaked
QART Medical
Alon Shalev
CEO

Board Members and Advisors

QART Medical
Eitan Dekel
Board Member
QART Medical
Keren Primor Cohen
Board Member

Funding Rounds

New wpDataTable

Date Announced

Funding Round

Amount Raised

Investors

AI Technology Stack

AI Description

The QART solution is based upon a first-in-class, stain-free, real-time 3D imaging system that provides a quantitative topographic map of the sperm morphology and its inner contents.

The system is a compact, stand-alone bench-top clinical workstation.

It is based upon a built-in quantitative phase interferometric microscopy (IPM) imaging microscopy platform, and has a microfluidics sorting stage, all controlled via a simple personal computer.

Per ICSI cycle, a disposable cartridge, containing the semen specimen, is inserted into the workstation.

AI employees
2
AI types
Computer Vision, Deep Learning
AI algorithms
DCGAN, GANs
AI tasks
3D

Research

Many medical and biological protocols for analyzing individual biological cells involve morphological evaluation based on cell staining, designed to enhance imaging contrast and enable clinicians and biologists to differentiate between various cell organelles. However, cell staining is not always allowed in certain medical procedures. In other cases, staining may be...

Sign up for free

  • Save profiles to your list
  • View all funding rounds
  • Advanced sorting filter access
  • Search investment rounds
  • Search exit events

Sign up for Pro

  • Export lists (CSV, Excel) of startups and investors
  • View newly added AI startups
  • View investor emails
  • View investment funds and rounds sources
  • Advanced filters, sorting and search
  • Starting at just $15 per month